AI Chat Paper
Discover the SciOpen Platform and Achieve Your Research Goals with Ease.
(
Extracellular vesicles (EVs) are tiny vesicles released by various cells that contain a variety of proteins, lipids, and nucleic acids, which can have a wide range of effects on other cells. The dynamic composition and contents of EVs can serve as sensitive biomarkers for diagnosing and monitoring various cardiovascular diseases (CVDs). In addition to their diagnostic potential, EVs are therapeutic agents capable of precise modulation and amelioration of CVDs, because of their innate ability to encapsulate and deliver bioactive molecules. This growing field reveals the intricate interplay between EVs and cardiovascular pathophysiology, showing that EVs can act as messengers of intercellular communication for CVD regenerative therapy. Extracellular vesicles serve as dual agents in the field of theranostics, both as diagnostic biomarkers able to decode nuanced molecular signatures of CVDs and as potent vehicles for targeted therapeutic interventions. This review delves into the evolving landscape of EVs, uncovering their diagnostic and therapeutic prospects and emphasizing their growing importance in shaping the future of cardiovascular theranostics.
Jeppesen DK, Zhang Q, Franklin JL, Coffey RJ. Extracellular vesicles and nanoparticles: emerging complexities. Trends Cell Biol. 2023;33(8):667–81. https://doi.org/10.1016/j.tcb.2023.01.002
Li RR, Wang C, Zhou MQ, Liu Y, Chen S, Chai Z, et al. Heparan sulfate proteoglycan‐mediated internalization of extracellular vesicles ameliorates liver fibrosis by targeting hepatic stellate cells. Extracell Vesicle. 2022;1:100018. https://doi.org/10.1016/j.vesic.2022.100018
Rädler J, Gupta D, Zickler A, Andaloussi SE. Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading. Mol Ther. 2023;31(5):1231–50. https://doi.org/10.1016/j.ymthe.2023.02.013
Keshtkar S, Azarpira N, Ghahremani MH. Mesenchymal stem cell‐derived extracellular vesicles: novel frontiers in regenerative medicine. Stem Cell Res Ther. 2018;9(1):63. https://doi.org/10.1186/s13287-018-0791-7
Jia YW, Yu L, Ma TL, Xu W, Qian H, Sun Y, et al. Small extracellular vesicles isolation and separation: current techniques, pending questions and clinical applications. Theranostics. 2022;12(15):6548–75. https://doi.org/10.7150/thno.74305
Gupta D, Zickler AM, El Andaloussi S. Dosing extracellular vesicles. Adv Drug Deliv Rev. 2021;178:113961. https://doi.org/10.1016/j.addr.2021.113961
Dixson AC, Dawson TR, Di Vizio D, Weaver AM. Context‐specific regulation of extracellular vesicle biogenesis and cargo selection. Nat Rev Mol Cell Biol. 2023;24(7):454–76. https://doi.org/10.1038/s41580-023-00576-0
Busatto S, Morad G, Guo P, Moses MA. The role of extracellular vesicles in the physiological and pathological regulation of the blood‐brain barrier. FASEB Bioadv. 2021;3(9):665–75. https://doi.org/10.1096/fba.2021-00045
Rigalli JP, Barros ER, Sommers V, Bindels RJM, Hoenderop JGJ. Novel aspects of extracellular vesicles in the regulation of renal physiological and pathophysiological processes. Front Cell Dev Biol. 2020;8:244. https://doi.org/10.3389/fcell.2020.00244
Gustafson D, Veitch S, Fish JE. Extracellular vesicles as protagonists of diabetic cardiovascular pathology. Front Cardiovasc Med. 2017;4:71. https://doi.org/10.3389/fcvm.2017.00071
Femminò S, Penna C, Margarita S, Comità S, Brizzi MF, Pagliaro P. Extracellular vesicles and cardiovascular system: biomarkers and cardioprotective effectors. Vascul Pharmacol. 2020;135:106790. https://doi.org/10.1016/j.vph.2020.106790
Hezam K, Wang C, Fu EZ, Zhou M, Liu Y, Wang H, et al. Superior protective effects of PGE2 priming mesenchymal stem cells against LPS‐induced acute lung injury (ALI) through macrophage immunomodulation. Stem Cell Res Ther. 2023;14(1):48. https://doi.org/10.1186/s13287-023-03277-9
Zhang KY, Li RR, Chen XN, Yan H, Li H, Zhao X, et al. Renal endothelial cell‐targeted extracellular vesicles protect the kidney from ischemic injury. Adv Sci. 2023;10(3):e2204626. https://doi.org/10.1002/advs.202204626
Zamani P, Fereydouni N, Butler AE, Navashenaq JG, Sahebkar A. The therapeutic and diagnostic role of exosomes in cardiovascular diseases. Trends Cardiovasc Med. 2019;29(6):313–23. https://doi.org/10.1016/j.tcm.2018.10.010
Hao T, Ji GB, Qian M, Li QX, Huang H, Deng S, et al. Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction. Sci Adv. 2023;9(48):eadi9967. https://doi.org/10.1126/sciadv.adi9967
Du W, Tao HY, Zhao SH, He ZX, Li Z. Translational applications of molecular imaging in cardiovascular disease and stem cell therapy. Biochimie. 2015;116:43–51. https://doi.org/10.1016/j.biochi.2015.06.021
Théry C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol. 2002;2(8):569–79. https://doi.org/10.1038/nri855
Burkova EE, Sedykh SE, Nevinsky GA. Human placenta exosomes: biogenesis, isolation, composition, and prospects for use in diagnostics. Int J Mol Sci. 2021;22(4):2158. https://doi.org/10.3390/ijms22042158
Akers JC, Gonda D, Kim R, Carter BS, Chen CC. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus‐like vesicles, and apoptotic bodies. J Neuro Oncol. 2013;113(1):1–11. https://doi.org/10.1007/s11060-013-1084-8
Davidson SM, Boulanger CM, Aikawa E, Badimon L, Barile L, Binder CJ, et al. Methods for the identification and characterization of extracellular vesicles in cardiovascular studies: from exosomes to microvesicles. Cardiovasc Res. 2023;119(1):45–63. https://doi.org/10.1093/cvr/cvac031
da Costa VR, Araldi RP, Vigerelli H, D'Ámelio F, Mendes TB, Gonzaga V, et al. Exosomes in the tumor microenvironment: from biology to clinical applications. Cells. 2021;10(10):2617. https://doi.org/10.3390/cells10102617
Han CS, Yang JJ, Sun JC, Qin G. Extracellular vesicles in cardiovascular disease: biological functions and therapeutic implications. Pharmacol Ther. 2022;233:108025. https://doi.org/10.1016/j.pharmthera.2021.108025
Eichner‐Seitz N. Diagnosis of extracellular vesicles in cardiovascular and metabolic diseases. Adv Exp Med Biol. 2023;1418:171–85. https://doi.org/10.1007/978-981-99-1443-2_12
Xiao X, Xu MQ, Yu HL, Wang L, Li X, Rak J, et al. Mesenchymal stem cell‐derived small extracellular vesicles mitigate oxidative stress‐induced senescence in endothelial cells via regulation of miR‐146a/Src. Signal Transduct Target Ther. 2021;6(1):354. https://doi.org/10.1038/s41392-021-00765-3
Gan L, Liu DM, Liu J, Chen E, Chen C, Liu L, et al. CD38 deficiency alleviates Ang Ⅱ‐induced vascular remodeling by inhibiting small extracellular vesicle‐mediated vascular smooth muscle cell senescence in mice. Signal Transduct Target Ther. 2021;6(1):223. https://doi.org/10.1038/s41392-021-00625-0
Giró O, Jiménez A, Pané A, Badimon L, Ortega E, Chiva‐Blanch G. Extracellular vesicles in atherothrombosis and cardiovascular disease: friends and foes. Atherosclerosis. 2021;330:61–75. https://doi.org/10.1016/j.atherosclerosis.2021.07.002
Hutcheson JD, Aikawa E. Extracellular vesicles in cardiovascular homeostasis and disease. Curr Opin Cardiol. 2018;33(3):290–7. https://doi.org/10.1097/HCO.0000000000000510
Liu H, Liu SY, Qiu XY, Yang X, Bao L, Pu F, et al. Donor MSCs release apoptotic bodies to improve myocardial infarction via autophagy regulation in recipient cells. Autophagy. 2020;16(12):2140–55. https://doi.org/10.1080/15548627.2020.1717128
Bouchareychas L, Duong P, Covarrubias S, Alsop E, Phu TA, Chung A, et al. Macrophage exosomes resolve atherosclerosis by regulating hematopoiesis and inflammation via microRNA cargo. Cell Rep. 2020;32(2):107881. https://doi.org/10.1016/j.celrep.2020.107881
Kreimer S, Belov AM, Ghiran I, Murthy SK, Frank DA, Ivanov AR. Mass‐spectrometry‐based molecular characterization of extracellular vesicles: lipidomics and proteomics. J Proteome Res. 2015;14(6):2367–84. https://doi.org/10.1021/pr501279t
Rosa‐Fernandes L, Rocha VB, Carregari VC, Urbani A, Palmisano G. A perspective on extracellular vesicles proteomics. Front Chem. 2017;5:102. https://doi.org/10.3389/fchem.2017.00102
de Hoog VC, Timmers L, Schoneveld AH, Wang JW, van de Weg SM, Sze SK, et al. Serum extracellular vesicle protein levels are associated with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care. 2013;2(1):53–60. https://doi.org/10.1177/2048872612471212
Kanhai DA, Visseren FLJ, van der Graaf Y, Schoneveld AH, Catanzariti LM, Timmers L, et al. Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease. Int J Cardiol. 2013;168(3):2358–63. https://doi.org/10.1016/j.ijcard.2013.01.231
Lopez JP, Nouri MZ, Ebrahim A, Chacko KM, Schramm WC, Gholam MF, et al. Lipid profiles of urinary extracellular vesicles released during the inactive and active phases of aged male mice with spontaneous hypertension. Int J Mol Sci. 2022;23(23):15397. https://doi.org/10.3390/ijms232315397
Chacko KM, Nouri MZ, Schramm WC, Malik Z, Liu LP, Denslow ND, et al. Tempol alters urinary extracellular vesicle lipid content and release while reducing blood pressure during the development of salt‐sensitive hypertension. Biomolecules. 2021;11(12):1804. https://doi.org/10.3390/biom11121804
Jung AL, Møller Jørgensen M, Bæk R, Artho M, Griss K, Han M, et al. Surface proteome of plasma extracellular vesicles as mechanistic and clinical biomarkers for malaria. Infection. 2023;51(5):1491–501. https://doi.org/10.1007/s15010-023-02022-x
Wang L, Liu J, Xu B, Liu Y, Liu Z. Reduced exosome miR‐425 and miR‐744 in the plasma represents the progression of fibrosis and heart failure. Kaohsiung J Med Sci. 2018;34(11):626–33. https://doi.org/10.1016/j.kjms.2018.05.008
Matsumoto S, Sakata Y, Suna S, Nakatani D, Usami M, Hara M, et al. Circulating p53‐responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013;113(3):322–6. https://doi.org/10.1161/CIRCRESAHA.113.301209
Chen ZZ, Yan YY, Wu JD, Qi C, Liu J, Wang J. Expression level and diagnostic value of exosomal NEAT1/miR‐204/MMP‐9 in acute ST‐segment elevation myocardial infarction. IUBMB Life. 2020;72(11):2499–507. https://doi.org/10.1002/iub.2376
Zheng ML, Liu XY, Han RJ, Yuan W, Sun K, Zhong J, et al. Circulating exosomal long non‐coding RNAs in patients with acute myocardial infarction. J Cell Mol Med. 2020;24(16):9388–96. https://doi.org/10.1111/jcmm.15589
Bei YH, Das S, Rodosthenous RS, Holvoet P, Vanhaverbeke M, Monteiro MC, et al. Extracellular vesicles in cardiovascular theranostics. Theranostics. 2017;7(17):4168–82. https://doi.org/10.7150/thno.21274
Chong SY, Lee CK, Huang CY, Ou YH, Charles CJ, Richards AM, et al. Extracellular vesicles in cardiovascular diseases: alternative biomarker sources, therapeutic agents, and drug delivery carriers. Int J Mol Sci. 2019;20(13):3272. https://doi.org/10.3390/ijms20133272
Li CW, Pei F, Zhu XS, Duan DD, Zeng C. Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem. 2012;45(10/11):727–32. https://doi.org/10.1016/j.clinbiochem.2012.04.013
Waldenström A, Gennebäck N, Hellman U, Ronquist G. Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One. 2012;7(4):e34653. https://doi.org/10.1371/journal.pone.0034653
Koosha F, Alimohammadi N, Rafeian‐Kopaei M. The exosomes: staring biomarkers and novel therapeutic strategies. Curr Pharm Des. 2021;27(35):3714–21. https://doi.org/10.2174/1381612827666210614102340
Zhou RH, Bozbas E, Allen‐Redpath K, Yaqoob P. Circulating extracellular vesicles are strongly associated with cardiovascular risk markers. Front Cardiovasc Med. 2022;9:907457. https://doi.org/10.3389/fcvm.2022.907457
Jansen F, Yang XY, Proebsting S, Hoelscher M, Przybilla D, Baumann K, et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc. 2014;3(6):e001249. https://doi.org/10.1161/JAHA.114.001249
D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31(22):2765–73. https://doi.org/10.1093/eurheartj/ehq167
Mateescu B, Kowal EJK, van Balkom BWM, Bartel S, Bhattacharyya SN, Buzás EI, et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA ‐ an ISEV position paper. J Extracell Vesicles. 2017;6(1):1286095. https://doi.org/10.1080/20013078.2017.1286095
Van Deun J, Mestdagh P, Agostinis P, Akay Ö, Anand S, Anckaert J, et al. EV‐TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods. 2017;14(3):228–32. https://doi.org/10.1038/nmeth.4185
Sherman CD, Lodha S, Sahoo S. EV cargo sorting in therapeutic development for cardiovascular disease. Cells. 2021;10(6):1500. https://doi.org/10.3390/cells10061500
Burtenshaw D, Regan B, Owen K, Collins D, McEneaney D, Megson IL, et al. Exosomal composition, biogenesis and profiling using point‐of‐care diagnostics‐implications for cardiovascular disease. Front Cell Dev Biol. 2022;10:853451. https://doi.org/10.3389/fcell.2022.853451
Zhou SS, Hu T, Zhang F, Tang D, Li D, Cao J, et al. Integrated microfluidic device for accurate extracellular vesicle quantification and protein markers analysis directly from human whole blood. Anal Chem. 2020;92(1):1574–81. https://doi.org/10.1021/acs.analchem.9b04852
Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8(7):727. https://doi.org/10.3390/cells8070727
Karimi N, Dalirfardouei R, Dias T, Lötvall J, Lässer C. Tetraspanins distinguish separate extracellular vesicle subpopulations in human serum and plasma ‐ contributions of platelet extracellular vesicles in plasma samples. J Extracell Vesicles. 2022;11(5):e12213. https://doi.org/10.1002/jev2.12213
Gardiner C, Di Vizio D, Sahoo S, Théry C, Witwer KW, Wauben M, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles. 2016;5(1):32945. https://doi.org/10.3402/jev.v5.32945
Schöler D, Loosen SH, Wirtz TH, Brozat JF, dos Santos Ferreira Grani LA, Luedde T, et al. Low extracellular vesicle concentrations predict survival in patients with heart failure. Front Cardiovasc Med. 2023;10:1163525. https://doi.org/10.3389/fcvm.2023.1163525
Trino S, Lamorte D, Caivano A, De Luca L, Sgambato A, Laurenzana I. Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy. Leukemia. 2021;35(3):661–78. https://doi.org/10.1038/s41375-020-01104-1
Shaba E, Vantaggiato L, Governini L, Haxhiu A, Sebastiani G, Fignani D, et al. Multi‐omics integrative approach of extracellular vesicles: a future challenging milestone. Proteomes. 2022;10(2):12. https://doi.org/10.3390/proteomes10020012
Chitoiu L, Dobranici A, Gherghiceanu M, Dinescu S, Costache M. Multi‐omics data integration in extracellular vesicle biology‐Utopia or future reality? Int J Mol Sci. 2020;21(22):8550. https://doi.org/10.3390/ijms21228550
Lee TH, D'Asti E, Magnus N, Al‐Nedawi K, Meehan B, Rak J. Microvesicles as mediators of intercellular communication in cancer—the emerging science of cellular ‘debris. Semin Immunopathol. 2011;33(5):455–67. https://doi.org/10.1007/s00281-011-0250-3
Jia G, Han Y, An YL, Ding Y, He C, Wang X, et al. NRP‐1 targeted and cargo‐loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–16. https://doi.org/10.1016/j.biomaterials.2018.06.029
Song Y, Zhang C, Zhang JX, Jiao Z, Dong N, Wang G, et al. Localized injection of miRNA‐21‐enriched extracellular vesicles effectively restores cardiac function after myocardial infarction. Theranostics. 2019;9(8):2346–60. https://doi.org/10.7150/thno.29945
Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu LM, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res. 2014;103(4):530–41. https://doi.org/10.1093/cvr/cvu167
Xing Z, Zhao C, Wu SW, Yang D, Zhang C, Wei X, et al. Hydrogel loaded with VEGF/TFEB‐engineered extracellular vesicles for rescuing critical limb ischemia by a dual‐pathway activation strategy. Adv Healthc Mater. 2022;11(5):e2100334. https://doi.org/10.1002/adhm.202100334
Zha Y, Li YW, Lin TY, Chen J, Zhang S, Wang J. Progenitor cell‐derived exosomes endowed with VEGF plasmids enhance osteogenic induction and vascular remodeling in large segmental bone defects. Theranostics. 2021;11(1):397–409. https://doi.org/10.7150/thno.50741
Mao CY, Li DJ, Zhou E, Gao E, Zhang T, Sun S, et al. Extracellular vesicles from anoxia preconditioned mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury. Aging. 2021;13(4):6156–70. https://doi.org/10.18632/aging.202611
Liu HB, Zhang YM, Yuan J, Gao W, Zhong X, Yao K, et al. Dendritic cell‐derived exosomal miR‐494‐3p promotes angiogenesis following myocardial infarction. Int J Mol Med. 2021;47(1):315–25. https://doi.org/10.3892/ijmm.2020.4776
Wang C, Liu C, Shi JX, Li H, Jiang S, Zhao P, et al. Nicotine exacerbates endothelial dysfunction and drives atherosclerosis via extracellular vesicle‐miRNA. Cardiovasc Res. 2023;119(3):729–42. https://doi.org/10.1093/cvr/cvac140
Liu SJ, Chen J, Shi J, Zhou W, Wang L, Fang W, et al. M1‐like macrophage‐derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment. Basic Res Cardiol. 2020;115(2):22. https://doi.org/10.1007/s00395-020-0781-7
Yuan W, Liang X, Liu YY, Wang H. Mechanism of miR‐378a‐3p enriched in M2 macrophage‐derived extracellular vesicles in cardiomyocyte pyroptosis after MI. Hypertens Res. 2022;45(4):650–64. https://doi.org/10.1038/s41440-022-00851-1
Zheng SY, Wang LS, Ma HY, Sun F, Wen F. MicroRNA‐129 overexpression in endothelial cell‐derived extracellular vesicle influences inflammatory response caused by myocardial ischemia/reperfusion injury. Cell Biol Int. 2021;45(8):1743–56. https://doi.org/10.1002/cbin.11614
Yadid M, Lind JU, Ardoña HAM, Sheehy SP, Dickinson LE, Eweje F, et al. Endothelial extracellular vesicles contain protective proteins and rescue ischemia‐reperfusion injury in a human heart‐on‐chip. Sci Transl Med. 2020;12(565):eaax8005. https://doi.org/10.1126/scitranslmed.aax8005
Liu BH, Lee BW, Nakanishi K, Villasante A, Williamson R, Metz J, et al. Cardiac recovery via extended cell‐free delivery of extracellular vesicles secreted by cardiomyocytes derived from induced pluripotent stem cells. Nat Biomed Eng. 2018;2(5):293–303. https://doi.org/10.1038/s41551-018-0229-7
Tian CH, Hu GK, Gao L, Hackfort BT, Zucker IH. Extracellular vesicular microRNA‐27a* contributes to cardiac hypertrophy in chronic heart failure. J Mol Cell Cardiol. 2020;143:120–31. https://doi.org/10.1016/j.yjmcc.2020.04.032
Bang C, Batkai S, Dangwal S, Gupta SK, Foinquinos A, Holzmann A, et al. Cardiac fibroblast‐derived microRNA passenger strand‐enriched exosomes mediate cardiomyocyte hypertrophy. J Clin Invest. 2014;124(5):2136–46. https://doi.org/10.1172/JCI70577
Saint‐Pol J, Gosselet F, Duban‐Deweer S, Pottiez G, Karamanos Y. Targeting and crossing the blood‐brain barrier with extracellular vesicles. Cells. 2020;9(4):851. https://doi.org/10.3390/cells9040851
Ramos‐Zaldívar HM, Polakovicova I, Salas‐Huenuleo E, Corvalán AH, Kogan MJ, Yefi CP, et al. Extracellular vesicles through the blood‐brain barrier: a review. Fluids Barriers CNS. 2022;19(1):60. https://doi.org/10.1186/s12987-022-00359-3
Kang JY, Mun D, Chun YM, Park D, Kim H, Yun N, et al. Engineered small extracellular vesicle‐mediated NOX4 siRNA delivery for targeted therapy of cardiac hypertrophy. J Extracell Vesicles. 2023;12(10):e12371. https://doi.org/10.1002/jev2.12371
Mentkowski KI, Lang JK. Exosomes engineered to express a cardiomyocyte binding peptide demonstrate improved cardiac retention in vivo. Sci Rep. 2019;9(1):10041. https://doi.org/10.1038/s41598-019-46407-1
Antes TJ, Middleton RC, Luther KM, Ijichi T, Peck KA, Liu WJ, et al. Targeting extracellular vesicles to injured tissue using membrane cloaking and surface display. J Nanobiotechnol. 2018;16(1):61. https://doi.org/10.1186/s12951-018-0388-4
Shao LB, Zhang Y, Pan XB, Liu B, Liang C, Zhang Y, et al. Knockout of beta‐2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell‐induced immune rejection. Cell Mol Life Sci. 2020;77(5):937–52. https://doi.org/10.1007/s00018-019-03220-3
Wei ZL, Qiao SH, Zhao JX, Liu Y, Li Q, Wei Z, et al. miRNA‐181a over‐expression in mesenchymal stem cell‐derived exosomes influenced inflammatory response after myocardial ischemia‐reperfusion injury. Life Sci. 2019;232:116632. https://doi.org/10.1016/j.lfs.2019.116632
Ma J, Zhao YY, Sun L, Sun X, Zhao X, Sun X, et al. Exosomes derived from akt‐modified human umbilical cord mesenchymal stem cells improve cardiac regeneration and promote angiogenesis via activating platelet‐derived growth factor D. Stem Cells Transl Med. 2017;6(1):51–9. https://doi.org/10.5966/sctm.2016-0038
Vader P, Mol EA, Pasterkamp G, Schiffelers RM. Extracellular vesicles for drug delivery. Adv Drug Deliv Rev. 2016;106:148–56. https://doi.org/10.1016/j.addr.2016.02.006
Chitti SV, Nedeva C, Manickam R, Fonseka P, Mathivanan S. Extracellular vesicles as drug targets and delivery vehicles for cancer therapy. Pharmaceutics. 2022;14(12):2822. https://doi.org/10.3390/pharmaceutics14122822
Wang X, Chen YH, Zhao ZN, Meng Q, Yu Y, Sun J, et al. Engineered exosomes with ischemic myocardium‐targeting peptide for targeted therapy in myocardial infarction. J Am Heart Assoc. 2018;7(15):e008737. https://doi.org/10.1161/JAHA.118.008737
Jansen F, Li Q, Pfeifer A, Werner N. Endothelial‐ and immune cell‐derived extracellular vesicles in the regulation of cardiovascular health and disease. JACC Basic Transl Sci. 2017;2(6):790–807. https://doi.org/10.1016/j.jacbts.2017.08.004
Kang JY, Kim H, Mun D, Yun N, Joung B. Co‐delivery of curcumin and miRNA‐144‐3p using heart‐targeted extracellular vesicles enhances the therapeutic efficacy for myocardial infarction. J Contr Release. 2021;331:62–73. https://doi.org/10.1016/j.jconrel.2021.01.018
Qiu C, Xia F, Zhang JZ, Shi Q, Meng Y, Wang C, et al. Advanced strategies for overcoming endosomal/lysosomal barrier in nanodrug delivery. Research. 2023;6:0148. https://doi.org/10.34133/research.0148
Nakase I, Futaki S. Combined treatment with a pH‐sensitive fusogenic peptide and cationic lipids achieves enhanced cytosolic delivery of exosomes. Sci Rep. 2015;5(1):10112. https://doi.org/10.1038/srep10112
Martinus RD, Goldsbury J. Endothelial TNF‐α induction by Hsp60 secreted from THP‐1 monocytes exposed to hyperglycaemic conditions. Cell Stress Chaperones. 2018;23(4):519–25. https://doi.org/10.1007/s12192-017-0858-x
He S, Wu C, Xiao J, Li D, Sun Z. Endothelial extracellular vesicles modulate the macrophage phenotype: potential implications in atherosclerosis. Scand J Immunol. 2018;87(4):e12648. https://doi.org/10.1111/sji.12648
Zhong X, Gao W, Wu RD, Liu H, Ge J. Dendritic cell exosome‐shuttled miRNA146a regulates exosome‐induced endothelial cell inflammation by inhibiting IRAK‐1: a feedback control mechanism. Mol Med Rep. 2019;20(6):5315–23. https://doi.org/10.3892/mmr.2019.10749
Park H, Huang X, Lu CM, Cairo MS, Zhou X. MicroRNA‐146a and microRNA‐146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins. J Biol Chem. 2015;290(5):2831–41. https://doi.org/10.1074/jbc.M114.591420
Konkoth A, Saraswat R, Dubrou C, Sabatier F, Leroyer AS, Lacroix R, et al. Multifaceted role of extracellular vesicles in atherosclerosis. Atherosclerosis. 2021;319:121–31. https://doi.org/10.1016/j.atherosclerosis.2020.11.006
Badimon L, Padro T, Arderiu G, Vilahur G, Borrell‐Pages M, Suades R. Extracellular vesicles in atherothrombosis: from biomarkers and precision medicine to therapeutic targets. Immunol Rev. 2022;312(1):6–19. https://doi.org/10.1111/imr.13127
Hergenreider E, Heydt S, Tréguer K, Boettger T, Horrevoets AJG, Zeiher AM, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14(3):249–56. https://doi.org/10.1038/ncb2441
Li QY, Huang ZY, Pang ZQ, Wang Q, Gao J, Chen J, et al. Targeted delivery of platelet membrane modified extracellular vesicles into atherosclerotic plaque to regress atherosclerosis. Chem Eng J. 2023;452:138992. https://doi.org/10.1016/j.cej.2022.138992
Wu GH, Zhang JF, Zhao QR, Zhuang W, Ding J, Zhang C, et al. Molecularly engineered macrophage‐derived exosomes with inflammation tropism and intrinsic heme biosynthesis for atherosclerosis treatment. Angew Chem Int Ed Engl. 2020;59(10):4068–74. https://doi.org/10.1002/anie.201913700
Kontaraki JE, Marketou ME, Zacharis EA, Parthenakis FI, Vardas PE. MicroRNA‐9 and microRNA‐126 expression levels in patients with essential hypertension: potential markers of target‐organ damage. J Am Soc Hypertens. 2014;8(6):368–75. https://doi.org/10.1016/j.jash.2014.03.324
Cengiz M, Yavuzer S, Kılıçkıran AB, Yürüyen M, Yavuzer H, Dikici SA, et al. Circulating miR‐21 and eNOS in subclinical atherosclerosis in patients with hypertension. Clin Exp Hypertens. 2015;37(8):643–9. https://doi.org/10.3109/10641963.2015.1036064
Zhang HG, Zhang QJ, Li BW, Li LH, Song XH, Xiong CM, et al. The circulating level of miR‐122 is a potential risk factor for endothelial dysfunction in young patients with essential hypertension. Hypertens Res. 2020;43(6):511–7. https://doi.org/10.1038/s41440-020-0405-5
Feng R, Ullah M, Chen K, Ali Q, Lin Y, Sun Z. Stem cell‐derived extracellular vesicles mitigate ageing‐associated arterial stiffness and hypertension. J Extracell Vesicles. 2020;9(1):1783869. https://doi.org/10.1080/20013078.2020.1783869
Wang C, Xing CY, Li ZL, Liu Y, Li Q, Wang Y, et al. Bioinspired therapeutic platform based on extracellular vesicles for prevention of arterial wall remodeling in hypertension. Bioact Mater. 2022;8:494–504. https://doi.org/10.1016/j.bioactmat.2021.06.005
Cheng PP, Wang XT, Liu Q, Yang T, Qu H, Zhou H. Extracellular vesicles mediate biological information delivery: a double‐edged sword in cardiac remodeling after myocardial infarction. Front Pharmacol. 2023;14:1067992. https://doi.org/10.3389/fphar.2023.1067992
de Abreu RC, Fernandes H, da Costa Martins PA, Sahoo S, Emanueli C, Ferreira L. Native and bioengineered extracellular vesicles for cardiovascular therapeutics. Nat Rev Cardiol. 2020;17(11):685–97. https://doi.org/10.1038/s41569-020-0389-5
Riaud M, Martinez MC, Montero‐Menei CN. Scaffolds and extracellular vesicles as a promising approach for cardiac regeneration after myocardial infarction. Pharmaceutics. 2020;12(12):1195. https://doi.org/10.3390/pharmaceutics12121195
Huang X, Zuo JH. Emerging roles of miR‐210 and other non‐coding RNAs in the hypoxic response. Acta Biochim Biophys Sin. 2014;46(3):220–32. https://doi.org/10.1093/abbs/gmt141
van Balkom BWM, Eisele AS, Pegtel DM, Bervoets S, Verhaar MC. Quantitative and qualitative analysis of small RNAs in human endothelial cells and exosomes provides insights into localized RNA processing, degradation and sorting. J Extracell Vesicles. 2015;4(1):26760. https://doi.org/10.3402/jev.v4.26760
Cambier L, de Couto G, Ibrahim A, Echavez AK, Valle J, Liu W, et al. Y RNA fragment in extracellular vesicles confers cardioprotection via modulation of IL‐10 expression and secretion. EMBO Mol Med. 2017;9(3):337–52. https://doi.org/10.15252/emmm.201606924
Youn SW, Li Y, Kim YM, Sudhahar V, Abdelsaid K, Kim H, et al. Modification of cardiac progenitor cell‐derived exosomes by miR‐322 provides protection against myocardial infarction through Nox2‐dependent angiogenesis. Antioxidants. 2019;8(1):18. https://doi.org/10.3390/antiox8010018
Yuan JP, Yang H, Liu CX, Shao L, Zhang H, Lu K, et al. Microneedle patch loaded with exosomes containing microRNA‐29b prevents cardiac fibrosis after myocardial infarction. Adv Healthc Mater. 2023;12(13):e2202959. https://doi.org/10.1002/adhm.202202959
Rogers RG, Ciullo A, Marbán E, Ibrahim AG. Extracellular vesicles as therapeutic agents for cardiac fibrosis. Front Physiol. 2020;11:479. https://doi.org/10.3389/fphys.2020.00479
Lee JY, Chung J, Byun Y, Kim KH, An SH, Kwon K. Mesenchymal stem cell‐derived small extracellular vesicles protect cardiomyocytes from doxorubicin‐induced cardiomyopathy by upregulating survivin expression via the miR‐199a‐3p‐akt‐Sp1/p53 signaling pathway. Int J Mol Sci. 2021;22(13):7102. https://doi.org/10.3390/ijms22137102
Li HF, Huang HY, Chen XN, Chen S, Yu L, Wang C, et al. The delivery of hsa‐miR‐11401 by extracellular vesicles can relieve doxorubicin‐induced mesenchymal stem cell apoptosis. Stem Cell Res Ther. 2021;12(1):77. https://doi.org/10.1186/s13287-021-02156-5
Aimaletdinov AM, Gomzikova MO. Tracking of extracellular vesicles' biodistribution: new methods and approaches. Int J Mol Sci. 2022;23(19):11312. https://doi.org/10.3390/ijms231911312
Hwang DW, Choi H, Jang SC, Yoo MY, Park JY, Choi NE, et al. Noninvasive imaging of radiolabeled exosome‐mimetic nanovesicle using (99m)Tc‐HMPAO. Sci Rep. 2015;5(1):15636. https://doi.org/10.1038/srep15636
Galisova A, Zahradnik J, Allouche‐Arnon H, Morandi MI, Abou Karam P, Fisler M, et al. Genetically engineered MRI‐trackable extracellular vesicles as SARS‐CoV‐2 mimetics for mapping ACE2 binding in vivo. ACS Nano. 2022;16(8):12276–89. https://doi.org/10.1021/acsnano.2c03119
Santelices J, Ou M, Hui WW, Edelmann M, Maegawa G. Fluorescent labeling of small extracellular vesicles (EVs) isolated from conditioned media. Bio Protoc. 2022;12(12):e4447. https://doi.org/10.21769/BioProtoc.4447
Levy D, Do MA, Zhang JY, Brown A, Lu B. Orchestrating extracellular vesicle with dual reporters for imaging and capturing in mammalian cell culture. Front Mol Biosci. 2021;8:680580. https://doi.org/10.3389/fmolb.2021.680580
Dehghani M, Gaborski TR. Fluorescent labeling of extracellular vesicles. Methods Enzymol. 2020;645:15–42. https://doi.org/10.1016/bs.mie.2020.09.002
Banerjee A, Lino M, Jesus C, Ribeiro Q, Abrunhosa A, Ferreira L. Imaging platforms to dissect the in vivo communication, biodistribution and controlled release of extracellular vesicles. J Contr Release. 2023;360:549–63. https://doi.org/10.1016/j.jconrel.2023.06.039
Scott A, Sueiro Ballesteros L, Bradshaw M, Power A, Lorriman J, et al. In vivo characterization of endogenous cardiovascular extracellular vesicles in larval and adult zebrafish. Arterioscler Thromb Vasc Biol. 2021;41(9):2454–68. https://doi.org/10.1161/ATVBAHA.121.316539
Durak‐Kozica M, Baster Z, Kubat K, Stępień E. 3D visualization of extracellular vesicle uptake by endothelial cells. Cell Mol Biol Lett. 2018;23(1):57. https://doi.org/10.1186/s11658-018-0123-z
Zomer A, Maynard C, Verweij FJ, Kamermans A, Schäfer R, Beerling E, et al. In Vivo imaging reveals extracellular vesicle‐mediated phenocopying of metastatic behavior. Cell. 2015;161(5):1046–57. https://doi.org/10.1016/j.cell.2015.04.042
Li L, Jiang W, Luo K, Song H, Lan F, Wu Y, et al. Superparamagnetic iron oxide nanoparticles as MRI contrast agents for non‐invasive stem cell labeling and tracking. Theranostics. 2013;3(8):595–615. https://doi.org/10.7150/thno.5366
Zhuo ZW, Wang JH, Luo YJ, Zeng R, Zhang C, Zhou W, et al. Targeted extracellular vesicle delivery systems employing superparamagnetic iron oxide nanoparticles. Acta Biomater. 2021;134:13–31. https://doi.org/10.1016/j.actbio.2021.07.027
Dabrowska S, Del Fattore A, Karnas E, Frontczak‐Baniewicz M, Kozlowska H, Muraca M, et al. Imaging of extracellular vesicles derived from human bone marrow mesenchymal stem cells using fluorescent and magnetic labels. Int J Nanomed. 2018;13:1653–64. https://doi.org/10.2147/IJN.S159404
Huang CY, Neupane YR, Lim XC, Shekhani R, Czarny B, Wacker MG, et al. Extracellular vesicles in cardiovascular disease. Adv Clin Chem. 2021;103:47–95. https://doi.org/10.1016/bs.acc.2020.08.006
Busato A, Bonafede R, Bontempi P, Scambi I, Schiaffino L, Benati D, et al. Labeling and magnetic resonance imaging of exosomes isolated from adipose stem cells. Curr Protoc Cell Biol. 2017;75(1):3.44.1–3.44.15. https://doi.org/10.1002/cpcb.23
Khan AA, de Rosales RTM. Radiolabelling of extracellular vesicles for PET and SPECT imaging. Nanotheranostics. 2021;5(3):256–74. https://doi.org/10.7150/ntno.51676
Hong CM, Gangadaran P, Oh JM, Rajendran RL, Gopal A, Zhu L, et al. Radioiodine labeling and in vivo trafficking of extracellular vesicles. Sci Rep. 2021;11(1):5041. https://doi.org/10.1038/s41598-021-84636-5
Almeida S, Santos L, Falcão A, Gomes C, Abrunhosa A. In vivo tracking of extracellular vesicles by nuclear imaging: advances in radiolabeling strategies. Int J Mol Sci. 2020;21(24):9443. https://doi.org/10.3390/ijms21249443
Arifin DR, Witwer KW, Bulte JWM. Non‐Invasive imaging of extracellular vesicles: Quo vaditis in vivo? J Extracell Vesicles. 2022;11(7):e12241. https://doi.org/10.1002/jev2.12241
Varga Z, Gyurkó I, Pálóczi K, Buzás EI, Horváth I, Hegedűs N, et al. Radiolabeling of extracellular vesicles with (99m)Tc for quantitative in vivo imaging studies. Cancer Biother Radiopharm. 2016;31(5):168–73. https://doi.org/10.1089/cbr.2016.2009
Lu CH, Chen YA, Ke CC, Chiu SJ, Chen CC, Hsieh YJ, et al. Preclinical characterization and in vivo imaging of (111)In‐labeled mesenchymal stem cell‐derived extracellular vesicles. Mol Imag Biol. 2021;23(3):361–71. https://doi.org/10.1007/s11307-020-01562-0
Gangadaran P, Li XJ, Lee HW, Oh JM, Kalimuthu S, Rajendran RL, et al. A new bioluminescent reporter system to study the biodistribution of systematically injected tumor‐derived bioluminescent extracellular vesicles in mice. Oncotarget. 2017;8(66):109894–914. https://doi.org/10.18632/oncotarget.22493
Zhang KY, Chen S, Sun HM, Wang L, Li H, Zhao J, et al. In vivo two‐photon microscopy reveals the contribution of Sox9(+) cell to kidney regeneration in a mouse model with extracellular vesicle treatment. J Biol Chem. 2020;295(34):12203–13. https://doi.org/10.1074/jbc.RA120.012732
Zhang K, Li Z. Molecular imaging of therapeutic effect of mesenchymal stem cell‐derived exosomes for hindlimb ischemia treatment. Methods Mol Biol. 2020;2150:213–25. https://doi.org/10.1007/7651_2019_221
Zhang CY, Shang YN, Chen XN, Midgley AC, Wang Z, Zhu D, et al. Supramolecular nanofibers containing arginine‐Glycine‐aspartate (RGD) peptides boost therapeutic efficacy of extracellular vesicles in kidney repair. ACS Nano. 2020;14(9):12133–47. https://doi.org/10.1021/acsnano.0c05681
Zhang KY, Zhao XN, Chen XN, Wei Y, Du W, Wang Y, et al. Enhanced therapeutic effects of mesenchymal stem cell‐derived exosomes with an injectable hydrogel for hindlimb ischemia treatment. ACS Appl Mater Interfaces. 2018;10(36):30081–91. https://doi.org/10.1021/acsami.8b08449
Wei YZ, Wu YF, Zhao RX, Zhang K, Midgley AC, Kong D, et al. MSC‐derived sEVs enhance patency and inhibit calcification of synthetic vascular grafts by immunomodulation in a rat model of hyperlipidemia. Biomaterials. 2019;204:13–24. https://doi.org/10.1016/j.biomaterials.2019.01.049
Herrmann IK, Wood MJA, Fuhrmann G. Extracellular vesicles as a next‐generation drug delivery platform. Nat Nanotechnol. 2021;16(7):748–59. https://doi.org/10.1038/s41565-021-00931-2
Harris DD, Sabe SA, Sabra M, Xu CM, Malhotra A, Broadwin M, et al. Intramyocardial injection of hypoxia‐conditioned extracellular vesicles modulates apoptotic signaling in chronically ischemic myocardium. JTCVS Open. 2023;15:220–8. https://doi.org/10.1016/j.xjon.2023.05.013
Zhao H, Chen XY, Hu GY, Li C, Guo L, Zhang L, et al. Small extracellular vesicles from brown adipose tissue mediate exercise cardioprotection. Circ Res. 2022;130(10):1490–506. https://doi.org/10.1161/CIRCRESAHA.121.320458
Scrimgeour LA, Potz BA, Aboul Gheit A, Liu Y, Shi G, Pfeiffer M, et al. Intravenous injection of extracellular vesicles to treat chronic myocardial ischemia. PLoS One. 2020;15(9):e0238879. https://doi.org/10.1371/journal.pone.0238879
Zhu LP, Tian T, Wang JY, He JN, Chen T, Pan M, et al. Hypoxia‐elicited mesenchymal stem cell‐derived exosomes facilitates cardiac repair through miR‐125b‐mediated prevention of cell death in myocardial infarction. Theranostics. 2018;8(22):6163–77. https://doi.org/10.7150/thno.28021
Dinh PUC, Paudel D, Brochu H, Popowski KD, Gracieux MC, Cores J, et al. Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis. Nat Commun. 2020;11(1):1064. https://doi.org/10.1038/s41467-020-14344-7
Zhao RJ, Wang LN, Wang T, Xian P, Wang H, Long Q. Inhalation of MSC‐EVs is a noninvasive strategy for ameliorating acute lung injury. J Contr Release. 2022;345:214–30. https://doi.org/10.1016/j.jconrel.2022.03.025
Huang AN, Liu Y, Qi X, Chen S, Huang H, Zhang J, et al. Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection. Stem Cell Res Ther. 2022;13(1):253. https://doi.org/10.1186/s13287-022-02922-z
Smyth T, Kullberg M, Malik N, Smith‐Jones P, Graner MW, Anchordoquy TJ. Biodistribution and delivery efficiency of unmodified tumor‐derived exosomes. J Contr Release. 2015;199:145–55. https://doi.org/10.1016/j.jconrel.2014.12.013
Xie YM, Bagby TR, Cohen MS, Forrest ML. Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies. Expert Opin Drug Deliv. 2009;6(8):785–92. https://doi.org/10.1517/17425240903085128
Murali VP, Holmes CA. Biomaterial‐based extracellular vesicle delivery for therapeutic applications. Acta Biomater. 2021;124:88–107. https://doi.org/10.1016/j.actbio.2021.01.010
Amini H, Namjoo AR, Narmi MT, Mardi N, Narimani S, Naturi O, et al. Exosome‐bearing hydrogels and cardiac tissue regeneration. Biomater Res. 2023;27(1):99. https://doi.org/10.1186/s40824-023-00433-3
Han CS, Zhou J, Liang C, Liu B, Pan X, Zhang Y, et al. Human umbilical cord mesenchymal stem cell derived exosomes encapsulated in functional peptide hydrogels promote cardiac repair. Biomater Sci. 2019;7(7):2920–33. https://doi.org/10.1039/c9bm00101h
Lai JL, Huang CB, Guo YX, Rao L. Engineered extracellular vesicles and their mimics in cardiovascular diseases. J Contr Release. 2022;347:27–43. https://doi.org/10.1016/j.jconrel.2022.04.046
Yamada Y, Kobayashi H, Iwasa M, Sumi S, Ushikoshi H, Aoyama T, et al. Postinfarct active cardiac‐targeted delivery of erythropoietin by liposomes with sialyl Lewis X repairs infarcted myocardium in rabbits. Am J Physiol Heart Circ Physiol. 2013;304(8):H1124–33. https://doi.org/10.1152/ajpheart.00707.2012
Tang JN, Shen DL, Caranasos TG, Wang Z, Vandergriff AC, Allen TA, et al. Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome. Nat Commun. 2017;8(1):13724. https://doi.org/10.1038/ncomms13724
Chuo STY, Chien JCY, Lai CPK. Imaging extracellular vesicles: current and emerging methods. J Biomed Sci. 2018;25(1):91. https://doi.org/10.1186/s12929-018-0494-5
Klyachko NL, Arzt CJ, Li SM, Gololobova OA, Batrakova EV. Extracellular vesicle‐based therapeutics: preclinical and clinical investigations. Pharmaceutics. 2020;12(12):1171. https://doi.org/10.3390/pharmaceutics12121171
Öztürk S, Elçin AE, Koca A, Elçin YM. Therapeutic applications of stem cells and extracellular vesicles in emergency care: futuristic perspectives. Stem Cell Rev Rep. 2021;17(2):390–410. https://doi.org/10.1007/s12015-020-10029-2
This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
